NCT00592488已完成1 期
Prospective, Randomized, Placebo-controlled, Double-Blinded, Phase II Pilot Study of Acetyl-L-carnitine in the Treatment of Patients With Septic Shock
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 13
- 试验地点
- 1
- 主要终点
- Mean Arterial Blood Pressure
研究概览
简要总结
This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic shock requiring vasopressors.
详细描述
This is a cross-over study which infuses ALC for 12 out of 18 hours (and placebo the other 6). Patients must have vasopressor-dependent septic shock and be free from renal failure, hepatic failure, and seizures to be eligible.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •documented or presumed infection
- •shock requiring vasopressors
排除标准
- •hepatic failure
研究组 & 干预措施
A
Other
Placebo for first 6 hours then Acetyl-L-Carnitine (ALC) for 12 hours
干预措施: Acetyl-L-Carnitine (Drug)
B
Other
Acetyl-L-Carnitine (ALC) for first 12 hours then placebo for next 6 hours
干预措施: Acetyl-L-Carnitine (Drug)
结局指标
主要结局
Mean Arterial Blood Pressure
时间窗: 18 hours
Mean Arterial blood pressure measured non-invasively at 18 hours
次要结局
- Vasopressor Dose(6-24 hours)
- Serum Lactate(12-36 hours)
研究者
Todd Rice
Assistant Professor
Vanderbilt University
研究点 (1)
Loading locations...
相似试验
进行中(未招募)
1 期
étude d'un traitement complémentaire de L-carnitine chez des patients en choc septique avec une défaillance rénale aiguepatients devant bénéficier d'un traitement pour choc septique, accompagné d'insuffisance rénale aigüeMedDRA version: 20.0Level: LLTClassification code 10040580Term: Shock septicSystem Organ Class: 100000019974EUCTR2016-001977-34-FRCHU de Nîmes272
进行中(未招募)
1 期
carnitine as an adjunct treatment for septic shock patients with acute kidney injury: a multicentre, randomized, 2-parallel group, superiority trialshock septicMedDRA version: 26.0Level: LLTClassification code: 10040580Term: Shock septic Class: 10021881CTIS2024-512508-21-00Centre Hospitalier Universitaire De Nimes272
终止
3 期
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney InjurySevere SepsisShock, SepticAcute Kidney InjuryNCT02664753Centre Hospitalier Universitaire de Nīmes254
已完成
2 期
Vitamin C and Septic ShockSepsisSeptic ShockNCT03338569University of Minnesota125
已完成
4 期
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's DiseaseAlzheimer DiseaseNCT02955706Dong-A ST Co., Ltd.265
